William Blair Investment Management LLC Purchases 1,943 Shares of Genpact Limited $G

William Blair Investment Management LLC increased its position in Genpact Limited (NYSE:GFree Report) by 23.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,393 shares of the business services provider’s stock after purchasing an additional 1,943 shares during the quarter. William Blair Investment Management LLC’s holdings in Genpact were worth $457,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cornerstone Planning Group LLC bought a new position in Genpact in the first quarter worth $27,000. Richardson Financial Services Inc. bought a new position in shares of Genpact during the first quarter valued at $35,000. SVB Wealth LLC bought a new position in shares of Genpact during the first quarter valued at $41,000. Steph & Co. bought a new position in shares of Genpact during the second quarter valued at $37,000. Finally, Kestra Investment Management LLC bought a new position in shares of Genpact during the first quarter valued at $56,000. 96.03% of the stock is owned by institutional investors.

Genpact Stock Performance

Genpact stock opened at $39.86 on Tuesday. The stock has a 50-day simple moving average of $42.60 and a 200 day simple moving average of $44.09. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.32. Genpact Limited has a 12-month low of $37.82 and a 12-month high of $56.76. The stock has a market capitalization of $6.95 billion, a price-to-earnings ratio of 13.24, a P/E/G ratio of 1.35 and a beta of 0.89.

Genpact (NYSE:GGet Free Report) last released its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.85 by $0.03. The business had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.23 billion. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.79 earnings per share. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. On average, research analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Tuesday, December 9th will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Tuesday, December 9th. Genpact’s dividend payout ratio (DPR) is presently 22.59%.

Analysts Set New Price Targets

G has been the subject of a number of analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Genpact in a report on Wednesday, October 8th. Needham & Company LLC lifted their price objective on Genpact from $50.00 to $53.00 and gave the company a “buy” rating in a report on Friday, August 8th. Deutsche Bank Aktiengesellschaft initiated coverage on Genpact in a report on Thursday, July 17th. They set a “hold” rating and a $47.00 price objective for the company. Mizuho lifted their price objective on Genpact from $48.00 to $51.00 and gave the company a “neutral” rating in a report on Tuesday, July 1st. Finally, JPMorgan Chase & Co. cut their price target on Genpact from $55.00 to $50.00 and set a “neutral” rating for the company in a report on Wednesday, August 20th. Three analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Genpact currently has a consensus rating of “Hold” and a consensus price target of $52.29.

Get Our Latest Stock Report on G

Insider Transactions at Genpact

In related news, CEO Balkrishan Kalra sold 55,000 shares of Genpact stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $43.36, for a total value of $2,384,800.00. Following the completion of the sale, the chief executive officer directly owned 295,246 shares in the company, valued at $12,801,866.56. This trade represents a 15.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Piyush Mehta sold 76,902 shares of Genpact stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $42.58, for a total value of $3,274,487.16. Following the completion of the sale, the senior vice president owned 134,880 shares of the company’s stock, valued at approximately $5,743,190.40. The trade was a 36.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.80% of the stock is owned by company insiders.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Read More

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.